Gyre Therapeutics, Inc. (GYRE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Gyre Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 125.48x | 85.20x | -16.85x | 265.01x | -4.76x | -32.68x |
| P/B Ratio | 5.95x | 16.26x | -98.95x | 14.35x | 10.18x | 23.86x |
| P/S Ratio | 5.41x | 9.74x | 13.80x | 5.96x | 57.00x | 86.66x |
| Profitability | ||||||
| Gross Margin | 95.4% | 96.3% | 95.9% | 95.3% | -4.5% | 56.3% |
| Operating Margin | 9.9% | 15.3% | -59.3% | 9.0% | -1141.0% | -273.9% |
| Net Margin | 4.3% | 11.4% | -81.9% | 2.3% | -1198.3% | -265.1% |
| EBITDA Margin | 12.0% | 16.8% | 17.9% | 10.1% | -1194.4% | -267.8% |
| Liquidity | ||||||
| Current Ratio | 5.60x | 3.32x | 2.85x | 4.06x | 3.63x | 5.03x |
| Quick Ratio | 5.04x | 2.99x | 2.64x | 3.56x | 3.63x | 5.03x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.03x | -0.03x | 0.01x | 0.06x | 0.02x |
YoY = year-over-year change. Source: FMP..